XML 97 R82.htm IDEA: XBRL DOCUMENT v3.6.0.2
Legal and U.S. Regulatory Proceedings (Details Textual)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 26, 2017
lawsuit
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Legal and U.S. Regulatory Proceedings Details [Line Items]      
Accrued costs for clean-up and remediation   $ 122  
Restricted cash included in other assets   $ 122 $ 124
Settlement terms   On December 4, 2015, Galderma Laboratories, L.P. and Galderma S.A. (collectively, “Galderma”) filed a complaint in the United States District Court for the Northern District of Texas against the Company alleging infringement of United States Patent No. 6,106,848 based upon the Company’s submission to the FDA of an ANDA seeking FDA approval to market clobetasol propionate lotion 0.05% before the expiration patent asserted in the complaint.  
Estimated Clean Up Costs      
Legal and U.S. Regulatory Proceedings Details [Line Items]      
Cost for clean-up and remediation   $ 889  
Subsequent Event      
Legal and U.S. Regulatory Proceedings Details [Line Items]      
Number of punitive class action antitrust lawsuits | lawsuit 8